<DOC>
	<DOC>NCT00108290</DOC>
	<brief_summary>In men with prostate cancer who do not have evidence of spread to bone or other sites on computed axial tomography (CAT) scan/bone scan but are still at significant risk of failing treatment with surgery or radiation alone, a combination of chemotherapy and hormone therapy is being given for 6 months followed by surgery to remove the prostate.</brief_summary>
	<brief_title>Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>High risk prostate cancer without evidence of bone metastasis.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>hormone therapy</keyword>
	<keyword>surgery</keyword>
	<keyword>PSA</keyword>
	<keyword>Gleason score</keyword>
</DOC>